MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS
Publication
, Conference
Harrison, SA; Bashir, M; Shim-Lopez, J; Song, K; Chen, H
Published in: HEPATOLOGY
October 1, 2019
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2019
Volume
70
Start / End Page
1257A / 1257A
Location
Boston, MA
Publisher
WILEY
Conference Name
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrison, S. A., Bashir, M., Shim-Lopez, J., Song, K., & Chen, H. (2019). MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS. In HEPATOLOGY (Vol. 70, pp. 1257A-1257A). Boston, MA: WILEY.
Harrison, Stephen A., Mustafa Bashir, Jennifer Shim-Lopez, Ken Song, and Hubert Chen. “MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS.” In HEPATOLOGY, 70:1257A-1257A. WILEY, 2019.
Harrison SA, Bashir M, Shim-Lopez J, Song K, Chen H. MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS. In: HEPATOLOGY. WILEY; 2019. p. 1257A-1257A.
Harrison, Stephen A., et al. “MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS.” HEPATOLOGY, vol. 70, WILEY, 2019, pp. 1257A-1257A.
Harrison SA, Bashir M, Shim-Lopez J, Song K, Chen H. MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS. HEPATOLOGY. WILEY; 2019. p. 1257A-1257A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2019
Volume
70
Start / End Page
1257A / 1257A
Location
Boston, MA
Publisher
WILEY
Conference Name
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics